Pethő L - Search Results

1

Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers.

Pethő L, Murányi J, Pénzes K, Gurbi B, Brauswetter D, Halmos G, Csík G, Mező G. Pethő L, et al. Int J Mol Sci. 2019 Oct 11;20(20):5027. doi: 10.3390/ijms20205027. Int J Mol Sci. 2019. PMID: 31614426 Free PMC article.

2

Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate.

Schreier VN, Pethő L, Orbán E, Marquardt A, Petre BA, Mező G, Manea M. Schreier VN, et al. Among authors: petho l. PLoS One. 2014 Apr 9;9(4):e94041. doi: 10.1371/journal.pone.0094041. eCollection 2014. PLoS One. 2014. PMID: 24718594 Free PMC article.

3

Overcharging Effect in Electrospray Ionization Mass Spectra of Daunomycin-Tuftsin Bioconjugates.

Pethő L, Mező G, Schlosser G. Pethő L, et al. Molecules. 2019 Aug 16;24(16):2981. doi: 10.3390/molecules24162981. Molecules. 2019. PMID: 31426442 Free PMC article.

4

Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.

Murányi J, Varga A, Gyulavári P, Pénzes K, Németh CE, Csala M, Pethő L, Csámpai A, Halmos G, Peták I, Vályi-Nagy I. Murányi J, et al. Among authors: petho l. Int J Mol Sci. 2019 Nov 8;20(22):5590. doi: 10.3390/ijms20225590. Int J Mol Sci. 2019. PMID: 31717403 Free PMC article.

5

[Optimization of peptide-drug conjugates for targeted tumor therapy].

Mezõ G, Biri-Kovács B, Pethõ L, Sabine S, Kiss K, Oláhné Szabó R, Ranđelović I, Tóvári J. Mezõ G, et al. Among authors: petho l. Magy Onkol. 2019 Dec 9;63(4):290-300. Epub 2019 Oct 21. Magy Onkol. 2019. PMID: 31821384 Free article. Hungarian.

6

Amphiphilic drug-peptide-polymer conjugates based on poly(ethylene glycol) and hyperbranched polyglycerol for epidermal growth factor receptor targeting: the effect of conjugate aggregation on in vitro activity.

Pethő L, Kasza G, Lajkó E, Láng O, Kőhidai L, Iván B, Mező G. Pethő L, et al. Soft Matter. 2020 Jun 24;16(24):5759-5769. doi: 10.1039/d0sm00428f. Soft Matter. 2020. PMID: 32530018

7

Structural Characterization of Daunomycin-Peptide Conjugates by Various Tandem Mass Spectrometric Techniques.

Borbély A, Pethő L, Szabó I, Al-Majidi M, Steckel A, Nagy T, Kéki S, Kalló G, Csősz É, Mező G, Schlosser G. Borbély A, et al. Among authors: petho l. Int J Mol Sci. 2021 Feb 6;22(4):1648. doi: 10.3390/ijms22041648. Int J Mol Sci. 2021. PMID: 33562082 Free PMC article.

8

Influence of the Drug Position on Bioactivity in Angiopep-2-Daunomycin Conjugates.

Pethő L, Oláh-Szabó R, Mező G. Pethő L, et al. Int J Mol Sci. 2023 Feb 4;24(4):3106. doi: 10.3390/ijms24043106. Int J Mol Sci. 2023. PMID: 36834514 Free PMC article.

9

In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas.

Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N. Cazzamalli S, et al. Among authors: petho l. ACS Omega. 2018 Nov 30;3(11):14726-14731. doi: 10.1021/acsomega.8b02350. Epub 2018 Nov 2. ACS Omega. 2018. PMID: 30533574 Free PMC article.

10

Erratum: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma.

Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N. Cazzamalli S, et al. Among authors: petho l. ACS Omega. 2018 Dec 5;3(12):16743. doi: 10.1021/acsomega.8b03183. eCollection 2018 Dec 31. ACS Omega. 2018. PMID: 31458304 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters